Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study.

Blood Adv · 2025 · PMC11986219 · PMID 39637307

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.1200

boldest claim

The sentences

a trend toward significanceP = .05actually significant

A trend toward significance was also observed for age (HR, 1.13; 95% CI, 1.0-1.27; P = .05) and BMI (HR, 0.81; 95% CI, 0.64-1.02; P = .08; supplemental Figure 13 ).

also in 3,729 other papers

borderline significanceP = .073so close (0.05 < p ≤ 0.1)

20 , 21 Interestingly our analysis demonstrated an inverse correlation with better survival for patients with a higher BMI, an advantage that retained borderline significance in the multivariate analysis ( P = .073; supplemental Figure 16 ).

also in 7,017 other papers

a nonsignificant trendP = .12not close (p > 0.1)

A nonsignificant trend toward better OS for later-enrolled patients was demonstrated when comparing all 4 quartiles ( P = .12; supplemental Figure 14 A).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.